泰州医药高新区（高港区）：打造“名校+名城”校地合作新标杆

Core Insights - The "Taizhou Day" event held at Peking University Medical School aimed to strengthen collaboration between academia and industry, focusing on the biopharmaceutical sector [1][2] - The establishment of the Peking University Medical School (Taizhou) Pharmaceutical Health Industry Innovation Center marks a significant step in creating a comprehensive high-end pharmaceutical innovation base [2] Group 1: Collaboration and Innovation - The partnership between Peking University Medical School and Taizhou has been formalized through the establishment of the "Peking University Medical School (Taizhou) Pharmaceutical Health Industry Innovation Center" in 2023 [2] - The innovation center is designed to integrate concept validation, entrepreneurial incubation, talent cultivation, innovation services, and clinical trials into a unified platform [2] - The collaboration has led to the establishment of a clinical research service matrix, providing a green channel for clinical trials for local pharmaceutical companies [2] Group 2: Talent and Resource Development - The innovation center has set up five major platforms, including biomedical analysis instruments and innovative drug research, and has recruited 12 chief scientists to foster interdisciplinary collaboration [2] - The partnership has facilitated the clinical trial process for 27 projects from 17 companies at Peking University affiliated hospitals, demonstrating effective support for local enterprises [2] - The collaboration has also resulted in the establishment of the Peking University New Drug Research Center (Taizhou) and has received recognition as a key laboratory in Taizhou [2][3]